Dr. Prina-Mello scientific interests are focused on advanced translation research in NanoMedicine (in vitro/ in vivo diagnostic, imaging and therapeutics), microfluidic, biomedical devices and tissue engineering applications of nanotechnology and nanomaterials. The continuous exploration of the dynamic interaction between nano-developed-products and biologically relevant models constitute the basic ground for DrPrina-Mello’s multidisciplinary scientific work within and outside The Trinity Translational Medicine Institute (TTMI), the AMBER (Advanced Materials and BioEngineering Research as Science Foundation Ireland funded centre), CRANN nanoscience institute and the School of Medicine.
Dr. Prina-Mello is part of the Executive Board of the European Technology Platform of Nanomedicine, as Chair of the Characterisation and Toxicology working group. At European level, he has been involved in several EC-H2020 and FP7 projects among these EU-NCL, NoCanTher, AMCARE, MULTIFUN, NAMDIATREAM and others. Among these, he is the principal investigator behind the TCD participation to the European Nanomedicine Characterisation Laboratory infrastructure project (H2020-Infra-1). DrPrina-Mello is also a lecturer in Nanomedicine and Translational Nanomedicine at the TTMI.